Literature DB >> 30776975

Markers or Makers: Inflammatory Cytokines in Treatment-Resistant Hypertension

Natalia R Barbaro1, David G Harrison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30776975      PMCID： PMC6416056          DOI： 10.1161/HYPERTENSIONAHA.119.12604

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Authors:  Wolfgang Hueber; Bruce E Sands; Steve Lewitzky; Marc Vandemeulebroecke; Walter Reinisch; Peter D R Higgins; Jan Wehkamp; Brian G Feagan; Michael D Yao; Marek Karczewski; Jacek Karczewski; Nicole Pezous; Stephan Bek; Gerard Bruin; Bjoern Mellgard; Claudia Berger; Marco Londei; Arthur P Bertolino; Gervais Tougas; Simon P L Travis
Journal:  Gut       Date:  2012-05-17       Impact factor: 23.059

3.  Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers.

Authors:  Natália Ruggeri Barbaro; Vanessa Fontana; Rodrigo Modolo; Ana Paula De Faria; Andrea Rodrigues Sabbatini; Francisco Helfenstein Fonseca; Gabriel F Anhê; Heitor Moreno
Journal:  Blood Press       Date:  2014-07-25       Impact factor: 2.835

4.  Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage.

Authors:  Xin Yu; Zhen Yang; Meiling Yu
Journal:  Ren Fail       Date:  2010-05       Impact factor: 2.606

5.  Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Authors:  Paul M Ridker; Brendan M Everett; Aruna Pradhan; Jean G MacFadyen; Daniel H Solomon; Elaine Zaharris; Virak Mam; Ahmed Hasan; Yves Rosenberg; Erin Iturriaga; Milan Gupta; Michelle Tsigoulis; Subodh Verma; Michael Clearfield; Peter Libby; Samuel Z Goldhaber; Roger Seagle; Cyril Ofori; Mohammad Saklayen; Samuel Butman; Narendra Singh; Michel Le May; Olivier Bertrand; James Johnston; Nina P Paynter; Robert J Glynn
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

6.  Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.

Authors:  Jing Chen; Joshua D Bundy; L Lee Hamm; Chi-Yuan Hsu; James Lash; Edgar R Miller; George Thomas; Debbie L Cohen; Matthew R Weir; Dominic S Raj; Hsiang-Yu Chen; Dawei Xie; Panduranga Rao; Jackson T Wright; Mahboob Rahman; Jiang He
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 7.  IL-6 blockade in chronic inflammatory diseases.

Authors:  Antonia Puchner; Stephan Blüml
Journal:  Wien Med Wochenschr       Date:  2014-10-22

8.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.

Authors:  L E Bautista; L M Vera; I A Arenas; G Gamarra
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

9.  Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.

Authors:  Tomasz J Guzik; Nyssa E Hoch; Kathryn A Brown; Louise A McCann; Ayaz Rahman; Sergey Dikalov; Jorg Goronzy; Cornelia Weyand; David G Harrison
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307

Review 10.  The immunology of hypertension.

Authors:  Allison E Norlander; Meena S Madhur; David G Harrison
Journal:  J Exp Med       Date:  2017-12-15       Impact factor: 14.307
View more
  3 in total

Review 1.  Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments?

Authors:  Mariana Rodrigues Pioli; Ana Paula de Faria
Journal:  Curr Hypertens Rep       Date:  2019-11-26       Impact factor: 5.369

Review 2.  Sex-Specific Mechanisms in Inflammation and Hypertension.

Authors:  Megan A Sylvester; Heddwen L Brooks
Journal:  Curr Hypertens Rep       Date:  2019-05-23       Impact factor: 5.369

Review 3.  Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension.

Authors:  Christopher L Souders; Jasenka Zubcevic; Christopher J Martyniuk
Journal:  Cell Mol Neurobiol       Date:  2021-02-16       Impact factor: 5.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.